Clinical Trial: Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07731425) titled 'Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival' on July 23.

Brief Summary: This study of current or former cancer patients will evaluate whether communicating data on overall survival data in addition to information on progression-free improves the accuracy of cancer patients' expectations about the survival benefits of new cancer drugs

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Cancer

Intervention: OTHER: FDA explanation for progression-free survival (control)

Progression-free survival

OTHER: FDA explanation for progression-free survival wi...